Personalised Medicine
Affordability is the reason that we today are turning to personalised medicine. Dr Dinesh Pendharkar, Cancer Specialist, Asian Institute of Oncology, SL […]
Say something
Affordability is the reason that we today are turning to personalised medicine. Dr Dinesh Pendharkar, Cancer Specialist, Asian Institute of Oncology, SL […]
Research has become relatively easy today with open source data analysis software, image analysis software and websites. Dr Harsh Mahajan, […]
Dr Ram Narain, utive Director, Kokilaben Dhirubhai Ambani Hospital Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute has set up yet another […]
A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than […]
Amarantus Biosciences, a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death […]
Researchers at University of Cincinnati in the US have developed a DNA-based biomarker blood test to complement the prostate-specific antigen (PSA) test currently used to screen men for prostate cancer.
AIIMS' step to ensure faster cure of cancers All India Institute of Medical Sciences(AIIMS) is going to install a new […]
A new radiology treatment that limits blood flowing to a man
Researchers at University of California, Los Angeles (UCLA) in the US have developed a device based on Velcro-like nanoscale technology to identify and capture tumour cells circulating in the blood.
It is uncanny to imagine a defence officer, who once held the responsibility of operating army tanks, is now a well-known CEO of a leading hospital in the country and saving lives of thousands of ailing patients each day
Researchers are developing a genetic test to predict prostate cancer aggressiveness, which could save men with low-risk tumours from unnecessary surgery.
Researchers at Dana-Farber Cancer Institute in the US have identified a signature of four molecular markers that can be used to predict if an existing prostate cancer is likely to remain dormant or spread to other parts of the body.
A study by researchers from the Kimmel Cancer Center at Jefferson says that the “longevity” protein SIRT1 can inhibit the development of a known precursor to prostate cancer. .